发明名称 |
BIOMARKERS FOR INFLAMMATORY RESPONSE |
摘要 |
An in-vitro method for the prediction, prognosis and/or diagnosis of an inflammatory response associated with a condition or disease such as schizophrenia in a subject, the method comprising determining in a sample of a subject the level of 25-hydroxy vitamin D3, preferably in combination with the level of least one biomarker wherein the at least one biomarker is selected from innate chemokine (IL-8) and matrix metalloproteinase (MMP-9); and comparing the levels of said 25-hydroxy vitamin D3 and at least one biomarker to a control level of 25-hydroxy vitamin D3 and the at least one biomarker respectively in order to determine a positive or negative prediction, prognosis and/or diagnosis of said inflammatory response indicating an associated condition or disease, such as schizophrenia. |
申请公布号 |
US2016131666(A1) |
申请公布日期 |
2016.05.12 |
申请号 |
US201414899546 |
申请日期 |
2014.06.17 |
申请人 |
MEIER Ute-Christiane |
发明人 |
MEIER Ute-Christiane |
分类号 |
G01N33/82;H01J49/00;G01N33/68 |
主分类号 |
G01N33/82 |
代理机构 |
|
代理人 |
|
主权项 |
1. An in vitro method for the prediction, prognosis and/or diagnosis of an inflammatory response associated with a condition or disease in a subject, the method comprising determining in a biological sample of a subject the level of vitamin D3; and comparing the levels of said vitamin D3 to a control level of vitamin D3 in order to determine a positive or negative prediction, prognosis and/or diagnosis of said inflammatory response associated with a disease or condition. |
地址 |
Munich DE |